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Abstract
Primary liver tumors in children are rare with malignant hepatoblastoma being the most common
neoplasm. In this report, we describe the diagnosis and clinical management of a large liver tumor
in a 3-year-old child that displayed the features of both, conventional hepatoblastoma and malignant
teratoma. Pathological assessment on a pre-operative bioptical specimen showed an immature
teratoid tumor with no area of hepatoblastic differentiation present. Histological and
immunhistological examination of the resected tumor specimen additionally showed tumor areas
of very different differentiation pattern intermixed with each other, namely areas of
hepatoblastoma-typical and neuroblastoma-like morphology as well as areas of
rhadomyosarcomatous differentiation.
After chemotherapy the tumor size increased and an extended right hemihepatectomy was
performed. Post-operatively, the general condition of the child improved and adjuvant
chemotherapy was started two weeks later. 36 months after initial diagnosis the patient is healthy,
in good general condition, and without any sign of residual tumor disease.
Overall, we describe the diagnosis and clinical management of a large liver tumor in a 3-year-old
child that displayed the features of both, conventional hepatoblastoma and malignant teratoma and
was designated as mixed hepatoblastoma and teratoma. Though mesenchymal tumor portions can
occur within hepatoblastomas, most commonly osteoid or chondroid, our case is different as it
presents a large spectrum of mesenchymal and epithelial differentiation pattern in most of the
lesion.
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Primary liver tumors in children are rare. The liver is
embryologically derived from both meso- and endoder-
mal tissues and, thus, can develop a wide variety of both
benign and malignant neoplasms. Hepatoblastoma is the
most common malignant hepatic neoplasm of child-
hood, representing about 75% of the primary liver tumors
in children in Western countries. Hepatic (benign or
malignant) teratoma is an extremely rare tumor with only
single cases reported world-wide [1-4]. In this report, we
describe the diagnosis and clinical management of a
mixed hepatoblastoma and teratoma of the liver in a 3-
year-old boy.
Clinical History and Histological Findings
A critically ill 3-year-old boy presented with a hard mass
beneath the right costal margin. Magnetic resonance tom-
ography showed a large, inhomogeneous mass measuring
10 × 9.5 × 7.3 cm with an intra- and extra-hepatic portion
(fig. 1a-c) and a partial compression of the vena cava infe-
rior, but no metastatic disease. Laboratory tests revealed
an increase of liver transaminases and a strong increase of
alpha-fetoprotein (AFP) and neuron-specific enolase.
Pathological assessment on a bioptical specimen showed
an immature teratoid tumor with no area of hepatoblastic
differentiation present. After a 5-day PEI chemotherapy
following the MAKEI 96 protocol of the German Society
for Pediatric Oncology and Hematology (GPOH) [5] AFP
decreased, but the tumor size increased to 14 × 14 × 20
cm. An extended right hemihepatectomy was performed.
The gross surgical specimen measured 23.5 × 16.8 × 11 cm
(1915 g) with a lesion size of 16 × 14 × 11 cm (fig. 1d) and
a minimal tumor-free margin of 0.3 cm. The tumor was
encapsulated and macroscopically showed multiple cysts
with a diameter of up to 1.5 cm, about 40% of the tumor
was necrotic.
The patient recovered well and showed no signs of further
tumor disease 36 months postoperatively.
MRI shows a large tumor in the right upper abdomen originating from the right liver lobeFigure 1
MRI shows a large tumor in the right upper abdomen originating from the right liver lobe. The tumor has two 
main parts and seems to contain different parts of tissue. The coronal view showed that the tumor is mainly situated outside 
the liver (a: T2 sequence). The transversal view reveals that the ventral tumor part has a cystic appearance, whereas the dorsal 
part appeared more solid (b: T2 sequence). The T1 sequence after contrast application (c) showed an inhomogeneous contrast 
enhancement. The ventral part of the tumor is enhancing a lot, the dorsal solid part does not enhance in the lateral regions. d: 
Macroscopic appearance of the resected tumor specimen.Page 2 of 5
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ferent differentiation pattern intermixed with each other
(i. e. not representing a collision tumor). Roughly, a fifth
of the examined tumor displayed a hepatoblastoma-typi-
cal morphology partly resembling embryonic and fetal
hepatoblastoma (fig. 2a, b). About 15% demonstrated a
neuroblastoma-like morphology (fig. 2e) and 5-10%
spindle-shaped areas with cross-striation being visible in
single cells (fig. 2h). The remaining tumor showed
necrotic tissue or grossly fibro-myxoid stroma-like areas as
well as multifocally mostly cystic epithelial structures (fig.
2m). Rarely, squameous differentiation or osteoid forma-
tion (fig. 2o, p) was seen.
Immunohistochemical analysis (antibodies are listed in
table 1; results in table 2) revealed expression of HepPar-
1 selectively in the hepatoblastic cells (fig. 2c) including a
significant amount of the cells within the necrotic tumor
areas (fig. 2d) suggesting that mostly the hepatoblastic
tumor portions were showing regression after chemother-
apy. No expression of AFP was found in any tumor por-
tion. The spindle-shaped cells presenting focally cross-
striation (fig. 2h: insert) expressed strongly desmin (fig.
2j), sarcomer actin (fig. 2k) and partly myogenin (fig. 2i)
in line with the rhabdomyosarcomatous phenotype of the
cells. The gland-like structures expressed epithelial cytok-
eratins (KL-1), particularly cytokeratins 7 (fig. 2n) and 19
(fig. 2o) similar to bile duct epithelia. CK5/6 was specifi-
cally positive in the areas of squameous differentiation
(fig. 2l). The small cell tumor component embedded in a
neurofibril-like material was positive for synaptophysin
(fig. 2f), neuron-specific enolase (NSE), S-100 protein
(fig. 2g), and CD56, which confirmed its neuroblastic dif-
ferentiation. CD-99 as well as TTF-1 (thyroid transcription
factor-1) was negative. The proliferation rate was 5 to 10%
except for in the spindle-cell areas, which showed an
increased proliferation rate (up to 30%).
FISH analysis demonstrated no amplification of the
MYCN-oncogene, which would have been an indicator of
a poor prognosis.
Post-operatively, the general condition of the child
improved and the first of four 10-day IPA chemotherapy
cycles following the HB 99 protocol of the GPOH was
started two weeks later. 36 months after initial diagnosis
the patient is healthy, in good general condition, and
without any sign of residual tumor disease.
Discussion
Hepatoblastoma is a rare, but the most common hepatic
malignancy of childhood with a peak incidence from 6
months to 3 years. The etiology of hepatoblastoma is
unknown, but it has been associated with Wiedemann-
Beckwith syndrome, familial adenomatosis polyposis
coli, prematurity and low birth weight. Hepatoblastomas
are well-defined, solid, mostly intrahepatical lesions.
Lymphatic and hematogenic metastases occur in
advanced disease stages with the latter mostly involving
the lungs. AFP levels are nearly always elevated in hepato-
blastomas and are correlated in most cases with the stage
of the disease [6]; also the rate of decline of AFP during
treatment is of prognostic value. The decrease of AFP dur-
ing chemotherapy, despite an increase in tumor size in
our case, is at first sight unusual, but most likely reflects a
rather high chemosensitivity of the hepatoblastoma
tumor portions. In the teratoma, areas kept proliferating
and were hardly affected. Correspondingly, the cells in the
areas of tumor necrosis were at least in part still positive
for HepPar-1.
Teratomas are rare neoplasms (incidence 0.7/100.000
children/year) with tissue derivatives of all three germ lay-
ers. Teratomas mostly occur in the ovaries, the sacrococcy-
geal region, the testes, and the central nerval system and
only rarely in other locations with less than 5% occurring
in the abdomen [7]. Teratomas are thought to have been
present since birth, or even before birth, and are therefore
considered as congenital tumors. In the liver, only single
cases of (benign or malignant) teratomas have been
described [1-4].
Our case represents a nearly unique combination of both
tumor entities, hepatoblastoma and malignant teratoma
in a young boy. Though mesenchymal tumor portions can
occur within hepatoblastomas, most commonly osteoid
or chondroid [8], our case is different as it presents a large
spectrum of mesenchymal and epithelial differentiation
pattern in most of the lesion. Obviously, the dispute
whether to call such a lesion mixed hepatoblastoma and
teratoma or teratoid hepatoblastoma [8] might be mostly
semantic. In our case, in which most of the lesion repre-
sented teratoma, however, we clearly prefer to talk about
a mixed or combined neoplasm, namely mixed hepatob-
lastoma and teratoma.
The treatment of the presented mixed hepatoblastoma
and teratoma of the liver was based on a combined sys-
temic chemotherapy and surgery. Therapies of such a
mixed tumor tissue have not been described yet, but chil-
dren with hepatoblastomas have nowadays, due to the
new therapy modalities, a rather good prognosis with a 5-
year survival rate of over 70% [9] with curative surgery
being the primary treatment of all pediatric liver tumors
especially in the absence of metastatic disease. Systemic
chemotherapy is beneficial as metastases are detectable at
diagnosis in about 20% of all patients and most children
suffer tumor recurrence after surgery alone.Page 3 of 5
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Conventional HE-staining demonstrated areas of embryonic (a) and fetal (b) hepatoblastic cells, which were positive for Hep-Par-1 (c)Figure 2
Conventional HE-staining demonstrated areas of embryonic (a) and fetal (b) hepatoblastic cells, which were 
positive for HepPar-1 (c). Of note, the tumor cells in the necrotic tumor portions were also focally still HepPar-1 positive 
(d). Other tumor areas showed tumor cells embedded into a fibrillar matrix (e) and revealed a strong positivity for synapto-
physin (f) as well as partly S-100 protein (g). In other areas a rhabdomyosarcomatous tumor cell differentiation (h; insert show-
ing focally visible cross-striation) with expression of myogenin (i), desmin (j) as well as sarcomer actin (k) was visible. 
Cytokeratin 5/6 expression was restricted to small foci of squameous differentiation (l). Areas of cystic epithelial differentiation 
(m) showed positivity for cytokeratins 7 (n) and 19 (o). Focally, osteoid formation was observed (p). (a,b,e,h,m,p: hematoxylin 
eosin; c,d,g,h,i-l,n,o: immunostainings with antibodies as indicated). (magnification bars a,b,i: 50 μm; c-h,j-p: 100 μm; l: 300 μm)
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In summary, we report on the diagnosis and clinical man-
agement of to our knowledge the second case of a mixed
hepatoblastoma and teratoma in a young boy [10].
Clearly, this represents a rare facet of embryonic tumors
within the liver. This case as well as similar cases with a
very peculiar tumor biology [11] documents the impor-
tance of adequate sampling of tumor material in all cases
of heterogenous tumor differentiation in order not to
miss minor, but relevant tumor portions. Management, as
far as it can be estimated from a single case, appears to be
along the guidelines valid for hepatoblastoma alone with,
however, the caveat that the (applied) chemotherapy was
only effective in the hepatoblastoma areas and not the ter-
atoma portion of the tumor.
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